Insider Selling: Afya (NASDAQ:AFYA) VP Sells $148,000.00 in Stock

Afya Limited (NASDAQ:AFYA) VP Gomiero Mirella Basolli sold 10,000 shares of the firm’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $14.80, for a total transaction of $148,000.00. Following the completion of the sale, the vice president owned 34,530 shares of the company’s stock, valued at $511,044. The trade was a 22.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Afya Price Performance

Shares of AFYA stock opened at $15.27 on Friday. Afya Limited has a 1 year low of $13.00 and a 1 year high of $17.68. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. The firm’s 50 day moving average is $14.28 and its 200-day moving average is $14.54. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of 9.98, a PEG ratio of 1.54 and a beta of 0.32.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AFYA. Van ECK Associates Corp lifted its position in shares of Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after purchasing an additional 1,377 shares in the last quarter. Daiwa Securities Group Inc. bought a new position in shares of Afya in the 4th quarter valued at about $43,000. Arrowstreet Capital Limited Partnership grew its holdings in shares of Afya by 5.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after acquiring an additional 3,626 shares in the last quarter. Militia Capital Partners LP acquired a new stake in shares of Afya in the second quarter valued at about $71,000. Finally, Fairtree Asset Management Pty Ltd raised its holdings in Afya by 22.3% during the fourth quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company’s stock worth $473,000 after acquiring an additional 5,599 shares in the last quarter. 88.02% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AFYA has been the topic of a number of recent research reports. JPMorgan Chase & Co. decreased their price objective on Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Wall Street Zen downgraded Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 2nd. Zacks Research lowered Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Monday, April 20th. Finally, Bank of America restated a “neutral” rating on shares of Afya in a report on Thursday, June 11th. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $17.10.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.